Insurance DTAs: Valuation Allowances and Admissibility

Insurance DTAs: Valuation Allowances and Admissibility

May 26, 2026

Article Summary

• Deferred tax asset (DTA) accounting requires significant judgment, especially when net operating losses (NOLs) make up the largest portion of the balance. While GAAP and statutory accounting use the same valuation allowance analysis, statutory accounting also applies admissibility limitations that can further reduce recognized surplus.

• The valuation allowance analysis centers on whether DTAs are “more likely than not” to be realized. Even when realization is supportable, statutory accounting rules related to reversal timing and surplus thresholds may still cause some or all of the DTA to be non-admitted.

• Negative evidence, such as cumulative losses, poor operating results, or unfavorable industry conditions, typically carries substantial weight because it is based on historical facts. Positive evidence must be objective, well documented, and supported by verifiable trends, contracts, or existing business activity.

• A strong DTA analysis looks beyond NOLs and considers all book-to-tax differences, including deferred tax liabilities (DTLs) related to loss reserves, deferred acquisition costs (DAC), depreciation, and investment accounting. Predictable DTL reversals can provide meaningful support for realizing DTAs.

• Successful DTA evaluations require coordination across tax, finance, actuarial, and operational teams. Clear documentation, disciplined forecasting, and proactive communication with management, auditors, regulators, and rating agencies are critical to supporting conclusions over time.

While the underlying accounting standards related to deferred tax assets (DTAs) are well established, applying them in practice often requires significant judgment, particularly when net operating losses (NOLs) are the largest contributing factor.

Although GAAP and statutory accounting may produce different reported outcomes for DTAs, the underlying valuation allowance analysis is fundamentally the same. However, statutory accounting adds a separate admissibility assessment that can further limit the amount recognized in surplus.

Same Valuation Allowance Analysis, Different Statutory Outcome

The starting point under both GAAP and statutory accounting is the same: DTAs must be evaluated to assess whether they are more likely than not to be realized. When that standard is not met, a valuation allowance is required. That analysis establishes the net DTA and separates questions of realizability from the later question of statutory admissibility. Statutory accounting then assesses whether, and to what extent, that net amount is admitted for purposes of statutory surplus.

These limitations, such as reversal timing and surplus thresholds, can result in partial or full non-admissibility even when the deferred tax asset is fully justified from a valuation allowance perspective.

The Role of Evidence in a Valuation Allowance Analysis

One of the most challenging aspects of evaluating DTAs is the weighting of positive and negative evidence.

Negative evidence is typically straightforward. Cumulative losses, recent operating results, and adverse industry trends are all highly visible indicators. Because they are grounded in historical performance, they tend to carry significant weight and are difficult to overcome.

Positive evidence, by contrast, is more difficult to establish. It must be based on objectively verifiable information and cannot rely solely on projections or optimistic forecasts. While future taxable income is inherently forward-looking, the support behind those projections must be tied to real, observable factors, such as existing business already in force, contractual arrangements, or established trends that are already underway.

This distinction becomes particularly important when significant negative evidence exists. In those situations, the threshold for sufficient positive evidence increases. Auditors and regulators place great emphasis on whether the evidence supporting realization is not only reasonable, but also well documented and consistent with broader financial assumptions.

In practice, this means that realizing a DTA is not simply a matter of demonstrating a path to profitability. It requires evidence that can withstand scrutiny today, not just expectations about tomorrow.

Looking Beyond Net Operating Losses

Although NOLs often drive the conversation, a comprehensive valuation allowance analysis must consider all underlying book-to-tax differences that contribute to DTAs and deferred tax liabilities (DTLs).

For insurance companies, other common temporary differences may also factor into the analysis. Deductible items can arise from reserves or accruals that are recognized later for tax than for book, while taxable temporary differences may arise from accelerated tax depreciation or certain investment basis differences. Identifying these items, and understanding whether they create future deductions or future taxable income, can materially affect both the valuation allowance conclusion and the extent to which existing DTAs are supported.

Not all sources of future potential taxable income carry equal weight. DTLs tied to structural differences with predictable reversal patterns tend to be viewed as stronger positive evidence than items dependent on discretionary actions or uncertain future events.

A thorough analysis requires not only identifying these differences, but also evaluating their timing, reliability, and interaction.

Managing Management Expectations

Another dynamic that consistently arises in these discussions is the natural pressure on management to avoid valuation allowances or non-admitted assets.

From a financial reporting perspective, these adjustments can reduce earnings and decrease statutory surplus, lowering the company's risk-based capital (RBC). They may also raise concerns with boards, regulators, or rating agencies. As a result, there is often a strong preference to support full realization and admissibility wherever possible.

However, a balanced and realistic approach is required. In that context, managing expectations early is critical. Helping stakeholders understand that valuation allowances and non-admitted DTAs are not necessarily signs of underperformance, but rather outcomes of conservative accounting frameworks, can lead to more effective and less contentious discussions.

It is also important to recognize that the valuation allowance analysis is reassessed each reporting period as facts and circumstances evolve. As a result, a company that records a valuation allowance in one year is not necessarily locked into that conclusion indefinitely. Improvements in operating results, changes in forecasts, or stronger positive evidence may support reducing, or even eliminating, a valuation allowance in future periods, while deterioration in performance or additional negative evidence may require it to increase.

Conclusion

Ultimately, the successful evaluation of DTAs requires more than technical compliance. It depends on coordination across tax, finance, actuarial, and operational teams, along with consistent forecasts, clear documentation, and a disciplined assessment of whether a position can be substantiated over time.

For insurers, the challenge is not simply applying the rules but applying them with a level of rigor that is credible to auditors, regulators, and internal stakeholders alike.

Frequently Asked Questions about Valuation Allowances, Admissibility, and Deferred Tax Assets

For additional guidance, please contact the Larson Insurance Team.